Annual CFO
$5.28 M
+$17.51 M+143.18%
31 December 2023
Summary:
Cytek Biosciences annual cash flow from operations is currently $5.28 million, with the most recent change of +$17.51 million (+143.18%) on 31 December 2023. During the last 3 years, it has fallen by -$9.88 million (-65.16%). CTKB annual CFO is now -65.16% below its all-time high of $15.16 million, reached on 31 December 2020.CTKB Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$13.22 M
+$7.02 M+113.10%
30 September 2024
Summary:
Cytek Biosciences quarterly cash flow from operations is currently $13.22 million, with the most recent change of +$7.02 million (+113.10%) on 30 September 2024. Over the past year, it has increased by +$17.46 million (+411.89%). CTKB quarterly CFO is now at all-time high.CTKB Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$32.89 M
+$17.46 M+113.13%
30 September 2024
Summary:
Cytek Biosciences TTM cash flow from operations is currently $32.89 million, with the most recent change of +$17.46 million (+113.13%) on 30 September 2024. Over the past year, it has increased by +$30.93 million (+1576.55%). CTKB TTM CFO is now at all-time high.CTKB TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTKB Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +143.2% | +411.9% | +1576.5% |
| 3 y3 years | -65.2% | +1038.8% | +203.9% |
| 5 y5 years | - | - | - |
CTKB Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -65.2% | +143.2% | at high | +240.1% | at high | +353.5% |
| 5 y | 5 years | -65.2% | +138.4% | at high | +240.1% | at high | +353.5% |
| alltime | all time | -65.2% | +138.4% | at high | +240.1% | at high | +353.5% |
Cytek Biosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $13.22 M(+113.1%) | $32.89 M(+113.1%) |
| June 2024 | - | $6.20 M(+56.8%) | $15.43 M(+141.9%) |
| Mar 2024 | - | $3.96 M(-58.4%) | $6.38 M(+20.8%) |
| Dec 2023 | $5.28 M(-143.2%) | $9.51 M(-324.4%) | $5.28 M(+169.2%) |
| Sept 2023 | - | -$4.24 M(+48.7%) | $1.96 M(-250.6%) |
| June 2023 | - | -$2.85 M(-199.7%) | -$1.30 M(-83.5%) |
| Mar 2023 | - | $2.86 M(-53.9%) | -$7.89 M(-35.5%) |
| Dec 2022 | -$12.23 M | $6.19 M(-182.5%) | -$12.23 M(-5.7%) |
| Sept 2022 | - | -$7.50 M(-20.5%) | -$12.98 M(+201.0%) |
| June 2022 | - | -$9.44 M(+537.8%) | -$4.31 M(-454.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$1.48 M(-127.2%) | $1.22 M(-73.8%) |
| Dec 2021 | $4.63 M(-69.5%) | $5.45 M(+369.3%) | $4.63 M(-57.2%) |
| Sept 2021 | - | $1.16 M(-129.7%) | $10.82 M(-8.7%) |
| June 2021 | - | -$3.91 M(-302.3%) | $11.85 M(-24.2%) |
| Mar 2021 | - | $1.94 M(-83.4%) | $15.65 M(+3.2%) |
| Dec 2020 | $15.16 M(-210.2%) | $11.64 M(+431.3%) | $15.16 M(+331.2%) |
| Sept 2020 | - | $2.19 M(-1910.7%) | $3.52 M(+165.5%) |
| June 2020 | - | -$121.00 K(-108.4%) | $1.32 M(-8.4%) |
| Mar 2020 | - | $1.45 M | $1.45 M |
| Dec 2019 | -$13.75 M | - | - |
FAQ
- What is Cytek Biosciences annual cash flow from operations?
- What is the all time high annual CFO for Cytek Biosciences?
- What is Cytek Biosciences annual CFO year-on-year change?
- What is Cytek Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Cytek Biosciences?
- What is Cytek Biosciences quarterly CFO year-on-year change?
- What is Cytek Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for Cytek Biosciences?
- What is Cytek Biosciences TTM CFO year-on-year change?
What is Cytek Biosciences annual cash flow from operations?
The current annual CFO of CTKB is $5.28 M
What is the all time high annual CFO for Cytek Biosciences?
Cytek Biosciences all-time high annual cash flow from operations is $15.16 M
What is Cytek Biosciences annual CFO year-on-year change?
Over the past year, CTKB annual cash flow from operations has changed by +$17.51 M (+143.18%)
What is Cytek Biosciences quarterly cash flow from operations?
The current quarterly CFO of CTKB is $13.22 M
What is the all time high quarterly CFO for Cytek Biosciences?
Cytek Biosciences all-time high quarterly cash flow from operations is $13.22 M
What is Cytek Biosciences quarterly CFO year-on-year change?
Over the past year, CTKB quarterly cash flow from operations has changed by +$17.46 M (+411.89%)
What is Cytek Biosciences TTM cash flow from operations?
The current TTM CFO of CTKB is $32.89 M
What is the all time high TTM CFO for Cytek Biosciences?
Cytek Biosciences all-time high TTM cash flow from operations is $32.89 M
What is Cytek Biosciences TTM CFO year-on-year change?
Over the past year, CTKB TTM cash flow from operations has changed by +$30.93 M (+1576.55%)